Dr. Michael Argenziano, MD

Michael Argenziano, MD, FACS, is Associate Chief of the Division of Cardiac, Thoracic, and Vascular Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. He also serves as the director of the Minimally Invasive Cardiac Surgery and Surgical Arrhythmia programs, director of the Cardiothoracic Surgery Research Laboratory and Clinical Research Program, and program director of the Cardiothoracic Surgery Residency program. Dr. Argenziano received his medical degree from Columbia University Vagelos College of Physicians and Surgeons, and completed his postgraduate training at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital.
Dr. Argenziano is board certified in Surgery and Thoracic Surgery. He is the immediate past president of the New York Society for Thoracic Surgery. He has authored more than 100 publications, presented at numerous scientific conferences, and received several grants and awards for his research. He has led two national trials of …robotic surgery, and his atrial fibrillation research has been supported by the TSFRE’s Career Development Award. He currently serves as Columbia’s principal investigator in the NIH/NHLBI Network for Cardiothoracic Surgical Investigations.

• Newyork Presbyterian Columbia University Irving Medical Center

CUIMC/Milstein Hospital Building

177 Fort Washington Ave

New York

NY

10032

USA

(800) 441-1682

• Thoracic Surgeon

• Septal Defect Repair
• Coronary Artery Bypass
• Heart Valve Procedures

• Accepts Medicare
• Accepts Medicaid
• AETNA
• Affinity Health Plan
• AgeWell
• Amerigroup of New Jersey
• AmeriHealth of New Jersey
• CIGNA
• Emblem/GHI
• Emblem/Hip
• Empire Blue Cross Blue Shield Healthplus
• Empire Blue Cross/Blue Shield
• Fidelis Care
• Healthfirst
• Horizon Blue Cross Blue Shield
• Local 1199
• Magnacare (National)
• Medicare
• Multiplan
• MVP Health Care
• QualCare
• Quality Health Management
• RiverSpring
• TRICARE
• UnitedHealthcare
• VNSNY CHOICE
• WellCare
• World Trade Center Health Plan

• Lung Cancer